6 results match your criteria: "Kanagawa Prefectual Ashigarakami Hospital[Affiliation]"

Article Synopsis
  • - This study aimed to compare the effectiveness of two first-line treatments for Helicobacter pylori eradication: a triple therapy featuring vonoprazan, amoxicillin, and metronidazole (VAM) versus another using vonoprazan, amoxicillin, and clarithromycin (VAC).
  • - Conducted in Japan with 124 participants, the trial showed that both treatments yielded similar success rates for eradication, around 91% for VAM and 89% for VAC, without significant differences between them.
  • - The results indicate that VAM can be considered an effective first-line treatment and suggests its classification as a grade B regimen, indicating a good potential for national insurance approval in Japan.
View Article and Find Full Text PDF

Background: Continuation maintenance therapy with pemetrexed (PEM) and bevacizumab (BEV) following induction therapy with cisplatin (CDDP), PEM, and BEV is beneficial in advanced non-squamous non-small-cell lung cancer (NS-NSCLC), but the survival benefit of addition of BEV to CDDP/PEM as induction therapy is still unclear. The aim of this phase II study was to evaluate the feasibility and safety of a CDDP/PEM/BEV regimen in Japanese patients with EGFR wild-type NS-NSCLC.

Patients And Methods: This study included 25 patients who receive intravenous CDDP, PEM, and BEV (15 mg/kg) from August 2010 to February 2013.

View Article and Find Full Text PDF

Objective We evaluated the safety and efficacy of vonoprazan-based amoxicillin and clarithromycin 7-day triple therapy (VAC) in comparison to proton pump inhibitor (PPI)-based (PAC) as a first-line treatment and vonoprazan-based amoxicillin and metronidazole 7-day triple therapy (VAM) in comparison to PPI-based (PAM) as a second-line treatment for the eradication of Helicobacter pylori in Japan. Methods We performed a non-randomized, multi-center, parallel-group study to compare first-line VAC to PAC and second-line VAM to PAM. A pre-planned subgroup analysis on CAM resistance was also performed.

View Article and Find Full Text PDF

Multiplex genomic test of mutation and fusion genes in small biopsy specimen of lung cancer.

J Exp Ther Oncol

July 2016

Pathology and Laboratory for Molecular Diagnostics, Kanagawa Cancer Center, Nakao 2-3-2, Asahi-ku, Yokohama 241-0815, Japan.

We evaluated multiple oncogenic mutations and fusion genes in small specimen obtained by bronchoscopy. Eight patients with lung cancer were recruited, 3 small cell lung cancer, 3 non-small cell lung cancer, 1 adenocarcinoma and 1 squamous cell carcinoma. A median value of extracted RNA and DNA amounts from specimen was 1573 ng (range 367.

View Article and Find Full Text PDF

Introduction: When esophagojejunostomy is performed using a circular stapler after laparoscopic total gastrectomy, fixing the anvil to the end of the esophagus is challenging. We describe an easy method for fixation of the anvil using a one-handed sliding-knot technique after the anvil has been inserted into the esophagus.

Materials And Surgical Technique: After removing the stomach, the main operator makes a whip stitch at the end of the esophagus using a long piece of monofilament string.

View Article and Find Full Text PDF

Squamous cell carcinoma (SCC) of the lung is moderately responsive to anticancer drugs, but no specific chemotherapy regimens have yet been established. We conducted a multicenter phase II study of nedaplatin (NP) and irinotecan (CPT) for SCC of the lung. Fifty patients underwent 4 to 6 cycles of chemotherapy comprising of NP at 100 mg/m(2) on day 1 and CPT at 60 mg/m(2) on days 1 and 8 every 4 weeks.

View Article and Find Full Text PDF